SGLT2 inhibitors play important roles in our new person-centric approach for managing T2D. Here’s my take on how SGLT2 inhibitors can be used to mitigate cardiovascular and renal disease, along with how I approach treatment selection in challenging clinical scenarios.
Learn about the role of SGLT-2 inhibitors in treating type 2 diabetes.
Access expert recommendations to individualize treatment and minimize CV, HF, and CKD risks for patients T2D
Hear expert discussion of the role of SGLT-2 inhibitors in treating type 2 diabetes.